NANEXA Share Price Performance

NANEXA Community Fair Values

DA
daemningen4500
Community Contributor
19,9% Novo Nordisk ownership on a small swedish biotech - could this be a significant technology?
Nanexa AB is a Swedish pharmaceutical company that specializes in drug delivery systems. Here's a brief overview of its corporate history, ownership, focus, and potential: Corporate History Nanexa was founded in 2007 and is headquartered in Uppsala, Sweden.
SEK 1.30
FV
58.8% overvalued intrinsic discount
28.21%
Revenue growth p.a.
0users have liked this narrative
0users have commented on this narrative
1users have followed this narrative
about 1 month ago author updated this narrative

View all narratives

Recent NANEXA News & Updates

No updates

Nanexa AB (publ) Key Details

Last Reported Earnings

Mar 31, 2025

Next Reporting Earnings

Aug 27, 2025

Earnings per share (EPS): -0.20
Gross Margin: 61.73%
Net Profit Margin: -77.08%
Debt/Equity Ratio: 23.2%

View full report ›

Nanexa AB (publ) Competitors

View more competitors

About NANEXA

Founded: 2007
Employees: 13
CEO: David Westberg
WebsiteView website: nanexa.com

Nanexa AB (publ), a pharmaceutical company, develops injectable drug products in the Nordic countries, rest of Europe, and North America. The company offers PharmaShell, a drug delivery system based on atomic layer deposition coating technology for controlled release of various types of active pharmaceutical substances. It also develops NEX-22, a glucagon-like peptide-1 analogue liraglutide that has completed Phase I trial for the treatment of type 2 diabetes; NEX-18, a depot drug from azacitidine to treat myelodysplastic syndrome; and NEX-20, a depot drug from lenalidomide for the treatment of multiple myeloma. The company has collaborations with Novo Nordisk and AstraZeneca for the development of pharmaceutical products with active substances. Nanexa AB (publ) was founded in 2007 and is based in Uppsala, Sweden.

Swedish Market Performance

7 Days: -3.5%
3 Months: 1.1%
1 Year: -0.4%
Year to Date: -1.5%

Over the last 7 days, the market has dropped 3.5%, driven by pullbacks in every sector, especially the Industrials sector. Although the market performance has been flat over the past year. Looking forward, earnings are forecast to grow by 17% annually. Market details ›

💥 How Agentic AI Could Change Every Industry

Richard Bowman

August 2025

This week, we’re diving deeper into the world of agentic AI. We’re zeroing in on the core technologies that make these intelligent agents actually reliably work. We explore what all this could mean for software, start-ups, and most importantly, the opportunities and risks each industry faces by adopting Agentic AI.

Last Week

Nanexa Stock Price